1-5 of 5
Keywords: Nasopharyngeal carcinoma
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clinicopathologic Features and Efficacy of Induction Chemotherapy in Nasopharyngeal Carcinoma: Real-World Experience

Subject Area:
Oncology
Nargiz Majidova, Murat Sarı, Fatma Akdag Kahvecioglu, Erkan Ozcan, Mutıianur Ozkorkmaz Akdag, Akif Dogan, Sedat Yıldırım, Sermin Dinc Sonusen, Emil Yunusov, Alper Yasar, Abdussamet Celebi, Nadiye Sever, Erkam Kocaaslan, Pınar Erel, Yesım Agyol, Alı Kaan Guren, Rukıye Arıkan, Selver Isık, Ozlem Balvan, Caglayan Geredelı, Kazım Uygun, Ilhan Hacibekiroglu, Osman Kostek, Ibrahım Vedat Bayoglu
Journal: Oncology Research and Treatment
Oncol Res Treat (2024) 47 (7-8): 360–367.
https://doi.org/10.1159/000537988
Published Online: 02 April 2024
... Balvan; Caglayan Geredelı; Kazım Uygun; Ilhan Hacibekiroglu; Osman Kostek; Ibrahım Vedat Bayoglu Introduction: Nasopharyngeal carcinoma (NPC) accounts for 0.01% of all carcinomas, and 70% of patients have locally advanced disease with a poor prognosis. The mainstay therapy is chemoradiotherapy (CRT...
View article titled, Clinicopathologic Features and Efficacy of Induction Chemotherapy in <span class="search-highlight">Nasopharyngeal</span> <span class="search-highlight">Carcinoma</span>: Real-World Experience
Open the PDF for Clinicopathologic Features and Efficacy of Induction Chemotherapy in <span class="search-highlight">Nasopharyngeal</span> <span class="search-highlight">Carcinoma</span>: Real-World Experience in another window
Journal Articles

A Prospective Study on Defining the Indications of Prophylactic Level IB Radiotherapy in Nasopharyngeal Carcinoma Based on a Risk Score Model

Subject Area:
Oncology
Xue Zhang, Jing-Jing Yuan, Jian-Wu Ding, Shou-Hua Zhang, Zhi-Lin Zhang, Rong-Huan Hu, Dan Gong, Jia-Li Hu, Zi-Wei Tu, Lei Zeng
Journal: Oncology Research and Treatment
Oncol Res Treat (2022) 45 (9): 471–479.
https://doi.org/10.1159/000525446
Published Online: 15 June 2022
...Xue Zhang; Jing-Jing Yuan; Jian-Wu Ding; Shou-Hua Zhang; Zhi-Lin Zhang; Rong-Huan Hu; Dan Gong; Jia-Li Hu; Zi-Wei Tu; Lei Zeng Objective: The aim of the study was to investigate clinical evidence for defining the indications of prophylactic level IB radiotherapy (RT) in nasopharyngeal carcinoma...
View article titled, A Prospective Study on Defining the Indications of Prophylactic Level IB Radiotherapy in <span class="search-highlight">Nasopharyngeal</span> <span class="search-highlight">Carcinoma</span> Based on a Risk Score Model
Open the PDF for A Prospective Study on Defining the Indications of Prophylactic Level IB Radiotherapy in <span class="search-highlight">Nasopharyngeal</span> <span class="search-highlight">Carcinoma</span> Based on a Risk Score Model in another window
Journal Articles

Retrospective Analysis of Induction Chemotherapy plus Concurrent Chemoradiotherapy under Intensity-Modulated Radiotherapy Mode for Locally Advanced Nasopharyngeal Carcinoma

Subject Area:
Oncology
Kai Liao, Hao-Yun Tao, Ze-Jiang Zhan, Wen-Ze Qiu, Rong-Hui Zheng
Journal: Oncology Research and Treatment
Oncol Res Treat (2021) 44 (11): 602–612.
https://doi.org/10.1159/000519278
Published Online: 01 October 2021
...Kai Liao; Hao-Yun Tao; Ze-Jiang Zhan; Wen-Ze Qiu; Rong-Hui Zheng Introduction: Nasopharyngeal carcinoma (NPC) originates from the mucous epithelium of the nasopharynx. Although induction chemotherapy plus concurrent chemoradiotherapy is the major therapeutic protocol used for locally advanced NPC...
View article titled, Retrospective Analysis of Induction Chemotherapy plus Concurrent Chemoradiotherapy under Intensity-Modulated Radiotherapy Mode for Locally Advanced <span class="search-highlight">Nasopharyngeal</span> <span class="search-highlight">Carcinoma</span>
Open the PDF for Retrospective Analysis of Induction Chemotherapy plus Concurrent Chemoradiotherapy under Intensity-Modulated Radiotherapy Mode for Locally Advanced <span class="search-highlight">Nasopharyngeal</span> <span class="search-highlight">Carcinoma</span> in another window
Journal Articles

The Glypican-4 Gene Polymorphism rs1048369 and Susceptibility to Epstein-Barr Virus-Positive and -Negative Nasopharyngeal Carcinoma in Northern China

Subject Area:
Oncology
Shuzhen Liu, Wen Liu, Danrui Zhao, Yan Zhang, Zhenzhen Zhao, Bing Luo
Journal: Oncology Research and Treatment
Oncol Res Treat (2019) 42 (11): 572–579.
https://doi.org/10.1159/000502753
Published Online: 13 September 2019
... about the polymorphism in nasopharyngeal carcinoma (NPC), which is a malignant tumor with a high prevalence of EBV. Objective: The distribution of GPC4 polymorphism rs1048369 was investigated in NPC patients, especially in those with EBV infection. The association between the polymorphism of GPC4...
View article titled, The Glypican-4 Gene Polymorphism rs1048369 and Susceptibility to Epstein-Barr Virus-Positive and -Negative <span class="search-highlight">Nasopharyngeal</span> <span class="search-highlight">Carcinoma</span> in Northern China
Open the PDF for The Glypican-4 Gene Polymorphism rs1048369 and Susceptibility to Epstein-Barr Virus-Positive and -Negative <span class="search-highlight">Nasopharyngeal</span> <span class="search-highlight">Carcinoma</span> in Northern China in another window
Journal Articles

Pretreatment Epstein-Barr Virus DNA Load and Cumulative Cisplatin Dose Intensity Affect Long-Term Outcome of Nasopharyngeal Carcinoma Treated with Concurrent Chemotherapy: Experience of an Institute in an Endemic Area

Subject Area:
Oncology
Weihong Wei, Zeli Huang, Shaoen Li, Hemei Chen, Guoyi Zhang, Shuxia Li, Weihan Hu, Tao Xu
Journal: Oncology Research and Treatment
Oncol Res Treat (2014) 37 (3): 88–95.
https://doi.org/10.1159/000360178
Published Online: 26 February 2014
... ) and pretreatment plasma levels of Epstein-Barr virus (EBV) DNA for nasopharyngeal carcinoma (NPC), and investigated the prognostic factors. Methods: We enrolled 214 patients diagnosed with NPC and treated with CCRT. 41 patients received weekly docetaxel and 173 weekly cisplatin. 62 received cumulative cisplatin...
View article titled, Pretreatment Epstein-Barr Virus DNA Load and Cumulative Cisplatin Dose Intensity Affect Long-Term Outcome of <span class="search-highlight">Nasopharyngeal</span> <span class="search-highlight">Carcinoma</span> Treated with Concurrent Chemotherapy: Experience of an Institute in an Endemic Area
Open the PDF for Pretreatment Epstein-Barr Virus DNA Load and Cumulative Cisplatin Dose Intensity Affect Long-Term Outcome of <span class="search-highlight">Nasopharyngeal</span> <span class="search-highlight">Carcinoma</span> Treated with Concurrent Chemotherapy: Experience of an Institute in an Endemic Area in another window